Prostate News Archive
16-Feb-2011
Could Hair Loss at 20 Signal Higher Prostate Cancer Risk?
TUESDAY, Feb. 15 (HealthDay News) -- Men with prostate cancer may be twice as likely to have started showing signs of male pattern baldness at the age of 20 than those without prostate cancer, a new French study suggests. Drug may slow growth of early prostate cancer
A new study suggests a way to help men with early, low-risk prostate cancer avoid being overtreated for a disease that in most cases will never threaten their lives. It found that a drug can slow the growth of these tumors in men who opt to be monitored instead of having treatment right away. PSA Test Cut-off Could Signal Low-Risk Prostate Cancer
TUESDAY, Feb. 15 (HealthDay News) -- Men who have a low prostate-specific antigen (PSA) score when they're first tested may not need to be screened annually and probably don't need to undergo a biopsy, a new study suggests. New Debate on PSA Test for Prostate Cancer
Men with a PSA (prostate-specific antigen) level of less than 1 nanogram per liter of blood can safely wait up to eight years between PSA screenings, researchers say. Balding at 20 Linked to Double Prostate Cancer Risk Later, Researchers Say
Men who show signs of balding at 20 are twice as likely to develop prostate cancer in their lifetimes than those who keep their manes or lose them later, according to a French study.
Back to Prostate News Archive
